Printer Friendly

Mental status after West Nile virus infection.

Mental status after acute West Nile virus infection has not been examined objectively. We compared Telephone Interview for Cognitive Status scores of 116 patients with West Nile fever or West Nile neuroinvasive disease. Mental status was poorer and cognitive complaints more frequent with West Nile neuroinvasive disease

**********

West Nile virus (WNV) outbreaks have been studied in Africa since 1937 and in the United States since the initial New York City outbreak in 1999 (1). Studies of these outbreaks typically include only hospitalized patients, use retrospective medical chart reviews, and do not include follow-up after discharge (1-5). Therefore, the long-term sequelae of WNV are largely unknown.

Mental status after West Nile virus infection is an important public health issue because many studies of hospitalized patients have reported continued complaints from the time of discharge (2,4,5) through 18 months later (6). A limitation of these studies is their reliance on self-report of cognitive deficits rather than objective examination. No study of WNV patients has used objective assessment of mental status to determine the severity of cognitive deficits after acute WNV infection in a large sample of WNV patients, despite the fact that altered mental status is reported in 46% (1,4) to 74% (3) of WNV patients at the time of discharge from the hospital. In addition, no studies have determined whether mental status changes are more prevalent in patients who had West Nile neuroinvasive disease (WNND) than in patients who had West Nile fever (WNF), which would be expected, given the diagnostic criteria and the reports of less frequent and less severe cognitive deficits from WNF patients (7).

The purpose of our study was to objectively compare mental status of patients with a diagnosis of WNND or WNF, 9 months after symptom onset. We used the Telephone Interview for Cognitive Status (TICS) and subjective cognitive complaints noted during interview. Of the 190 eligible patients, all were seropositive for WNV and all had been reported to the New Mexico State Department of Health in 2003 (8). We successfully contacted 129 (68%) of these patients by telephone and excluded 13 who had received a diagnoses of a neurologic condition before the diagnosis of WNV infection or who did not speak English well. For the remaining 116 patients, diagnosis of WNND or WNF was made without knowledge of TICS score and was based on the reporting physician's diagnosis or medical record review for patients who were hospitalized for WNV infection or who had continuing neurologic or cognitive symptoms at the time of interview. Patients were evaluated with the TICS, which is highly correlated with the Mini Mental Status Examination (9), is sensitive to mental status deficits in the elderly (10,11), and is standardized for administration by telephone (12).

Table 1 shows that the WNF and WNND groups were comparable in age, sex, and ethnicity (p>0.05). However, because of a trend for lower education in the WNND group (p = 0.05), education was a covariate in all analyses. Analysis of covariance (ANCOVA) showed TICS total score to be poorer for the WNND than the WNF group (p = 0.005). Thus, a small, but consistent, effect suggests that WNV infection severity affects mental status.

Participants were also asked questions about current cognitive functioning (Table 2). Frequency of self-report of cognitive problems varied from 6% to 42% across both groups. Logistic regression, when controlled for education, showed reports of concentration difficulty (p = 0.05) and confusion (p = 0.02) to be significantly higher in the WNND group. Overall, the WNND group reported more cognitive problems than the WNF group (1.6 vs. 0.8, respectively, p = 0.009), and the number of cognitive problems was correlated with the TICS total score (r = -0.21, p = 0.02). These findings indicate that self-reported cognitive problems increased with severity of WNV infection.

To determine the better predictor of WNV diagnostic category--TICS total score, rate of cognitive problems, or a combination--we performed a logistic regression predicting WNV diagnostic category from TICS total and rates of self-report of cognitive problems. Only the TICS total score significantly predicted WNND group membership (p = 0.01), but rate of report of cognitive problems was a marginal predictor (p = 0.07).

This is the first study to objectively measure mental status after WNV infection except for 1 review paper that mentioned a study that performed neuropsychological evaluation of WNV patients while they were hospitalized with acute infection (13). We show that 9 months after infection, WNND produces subtle but consistently greater mental status deficits than WNF. These findings are consistent with those of studies that identified a high incidence of cognitive problems from WNV patients and lesser complaints from WNF patients (7) from time of hospital discharge through 18 months later (2,4,6,14). We found subtle cognitive deficits in the WNND group that could not be explained by demographic variables. Although these cognitive differences are subtle, they suggest that WNND produces cognitive deficits after the acute symptoms have largely dissipated. Our data may underestimate the incidence of cognitive changes associated with WNND because more sensitive comprehensive neuropsychologic evaluations were not done.

Similar to previous studies (5,6,14) of chronic cognitive complaints after WNV infection, our study showed a high incidence of cognitive complaints, although subjective self-reports can be unreliable. Our data show that although [approximately equal to] 24% of the WNV patients complained of cognitive problems, complaints were somewhat greater for patients in the WNND group than in the WNF group. In addition, subjective reports of cognitive problems are only marginally associated with poorer mental status. This finding further supports the need to perform objective mental status examinations, especially because normal variation in cognitive performance can be misattributed to a medical diagnosis (15).

We were not able to determine whether the WNF group demonstrated cognitive deficits because we did not include a healthy control group and because TICS does not have normative data for respondents <60 years of age. However, the published norms for TICS recommend a cutoff score of [greater than or equal to] 33 for classification as "normal" and [less than or equal to] 25 as clearly "impaired"; only 53% of our total sample fell into the normal range, despite being younger than the age for which norms are published (9). Furthermore, 33% of the WNF group scored in the abnormal range, suggesting that WNF may produce cognitive deficits relative to published norms. Although the influence of demographic differences (e.g., education) between the WNF and the normative group cannot be ruled out, the high incidence of abnormal scores in the WNF group may also reflect undiagnosed neuroinvasion of WNV. However, without a demographically matched control group, this question cannot be addressed definitively. In addition, 65% of the WNND group scored in the abnormal range, consistent with our other findings that WNND is associated with chronic mental status changes.

Our study has several advantages, including objective assessment of mental status, sampling from the entire state's reported cases of WNV infection in 1 year, direct comparison between WNF and WNND groups, and inclusion of patients of minority race and ethnicity. One potential limitation is the use of the reporting physician's diagnosis, but medical records were obtained for 78% of those at greatest risk for WNND. In all instances in which diagnosis was changed on the basis of medical records, WNF diagnosis was changed to WNND. Therefore, if we misclassified patients, we are more likely to have included in the WNF group patients who should have been in the WNND group; this potential bias would have decreased group differences by lowering the WNF mental status score.

These results emphasize that objective mental status assessment is more sensitive than subjective report and suggest that future studies should assess potential mental status deficits to clarify the long-term public health consequences of WNV.

Dr Haaland is a VA research career scientist at the New Mexico VA Healthcare System and professor of psychiatry and neurology at the University of New Mexico School of Medicine.

References

(1.) Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-14.

(2.) Pepperell C, Rau N, Krajden S, Kern R, Humar A, Mederski B, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003;168:1399-405.

(3.) Jeha LE, Sila CA, Lederman RJ, Prayson RA, Isada CM, Gordon SM. West Nile virus infection: a new acute paralytic illness. Neurology. 2003;61:55-9.

(4.) Brilla R, Block M, Geremia G, Wichter M. Clinical and neuroradiologic features of 39 consecutive cases of West Nile virus meningoencephalitis. J Neurol Sci. 2004;220:37-40.

(5.) Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Martin AA, Van Gerpen JA, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511-5.

(6.) Klee AL, Maidin B, Edwin B, Poshni I, Mostashari F, Fine A, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis. 2004; 10:1405-11.

(7.) Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, et al. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med. 2004;141:360-5.

(8.) Echevarria L, Pergam S, Goade D, Davis L, Ettestad P, Sewell M, et al. Persistence of symptoms in West Nile virus from 2003 New Mexico outbreak. Presented at the Western Regional Meeting of the American Federation for Medical Research, February 3, 2005, Carmel (CA).

(9.) Brandt J, Folstein MF. Telephone Interview for Cognitive Status. Lutz (FL): PAR--Psychological Assessment Resources, Inc.; 2003.

(10.) Lines CR, McCarroll KA, Lipton RB, Block GA. Telephone screening for amnestic mild cognitive impairment. Neurology. 2003;60:261-6.

(11.) Plassman BL, Newman TT, Welsh KA, Helms M, Breitner JCS. Properties of the Telephone Interview for Cognitive Status: application in epidemiological and longitudinal studies. Neuropsychiatry Neuropsychol Behav Neurol. 1994;7:235-41.

(12.) Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6:49-62.

(13.) Arciniegas DB, Anderson CA. Viral encephalitis: neuropsychiatric and neurobehavioral aspects. Curt Psychiatry Rep. 2004;6:372-9.

(14.) Burton JM, Kern RZ, Halliday W, Mikulis D, Brunton J, Fearon M, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci. 2004;31:185-93.

(15.) Putnam SH, Millis SR. Psychosocial factors in the development and maintenance of chronic somatic and functional symptoms following mild traumatic brain injury. Advances in Medical Psychotherapy. 1994;7:1-22.

Address for correspondence: Kathleen Y. Haaland, Research Service (151), NMVA Healthcare System, 1501 San Pedro SE, Albuquerque, NM 87108, USA; email: khaaland@unm.edu

Kathleen Y. Haaland,* ([dagger]) Joseph Sadek, * ([dagger]) Steven Pergam, ([dagger]) ([double dagger]) Leonor A. Echevarria, ([dagger]) [section] Larry E. Davis, * ([dagger]) Diane Goade, ([dagger]) Jeanne Harnar, * ([dagger]) Robert A. Nofchissey, ([dagger]) C. Mack Sewel, [paragraph] and Paul Ettestad [paragraph]

* New Mexico Veterans Affairs Healthcare System, Albuquerque, New Mexico, USA; ([dagger]) University of New Mexico, Albuquerque, New Mexico, USA; ([double dagger]) University of Washington, Seattle, Washington, USA; [section] Northwest Mississippi Regional Medical Center, Clarksdale, Mississippi, USA; and [paragraph] New Mexico Department of Health, Santa Fe, New Mexico, USA
Table 1. Demographic data from Telephone Interview for
Cognitive Status * ([dagger])

 West Nile
 West Nile neuroinvasive
Characteristic fever, n = 64 disease, n = 52 p value

Age, y 50.0 (12.8) 53.6 (19.1) 0.26
Education, y 14.6 (2.6) 13.6 (3.0) 0.05
Sex, % male 44 58 0.14
Ethnicity
 % white 62 64 0.90
 % Hispanic 33 31 0.90
Hospitalized, n (%) 10 (16) 40 (78) <0.001
TICS total 33.6 (3.3) 31.1 (3.8) 0.005 ([double
(range 0-41) dagger])

* TICS, Telephone Interview for Cognitive Status.

([dagger]) Means with standard deviations in parentheses, except
where otherwise indicated.

([double dagger]) p value, after analysis of covariance, controlling
for marginal group difference in education.

Table 2. Percentage of patients reporting current cognitive
problems

 West Nile
 West Nile neuroinvasive
Mental deficit fever disease Overall

Concentration 22 42* 31
Memory 28 42 35
Understanding 11 27 18
Decision making 16 25 20
Confusion 6 25* 15
Mean rate of 17 32 24
companies

* p < 0.05, after logistic regression, controlling for marginal
group difference in education.
COPYRIGHT 2006 U.S. National Center for Infectious Diseases
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:DISPATCHES
Author:Ettestad, Paul
Publication:Emerging Infectious Diseases
Geographic Code:1USA
Date:Aug 1, 2006
Words:2058
Previous Article:Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004.
Next Article:Human metapneumovirus, Australia, 2001-2004.
Topics:


Related Articles
Dead bird clusters as an early warning system for West Nile virus activity. (Research).
West Nile virus, Guadeloupe.
West Nile virus encephalitis in a Barbary macaque (Macaca sylvanus).
Dead crow reports and location of human West Nile virus cases, Chicago, 2002.
West Nile Virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas.
Long-term prognosis for clinical West Nile virus infection.
Clinical description and follow-up investigation of human West Nile virus cases.
Epidemiology and transmission dynamics of West Nile virus disease.
Virology, pathology, and clinical manifestations of West Nile Virus disease.
Follow-up of 2003 human West Nile virus infections, Denver, Colorado.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters